Barclays lowered the firm’s price target on Fresenius Medical (FMS) to EUR 40.50 from EUR 42.50 and keeps an Equal Weight rating on the shares.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS:
- Fresenius Medical Care Announces AGM and New Capital Structure
- Fresenius Medical Care Completes Bond Tender Offer with Increased Acceptance
- Fresenius Medical Care AG Announces Strategic Debt Management Initiative
- Fresenius Medical Care Secures €1.1 Billion Through Bond Issuance
- Fresenius Medical Care’s Earnings Call Highlights Growth and Challenges